| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 01/10/2013 | WO2012134104A3 Microbial fuel cell comprising a microprobe array |
| 01/10/2013 | WO2012118539A3 Automated particulate concentration system |
| 01/10/2013 | WO2012109353A9 Growth hormone receptor deficiency causes a major reduction in pro-aging signaling, cancer and diabetes in humans |
| 01/10/2013 | WO2012106668A3 Multifunctional probe-primers |
| 01/10/2013 | WO2012099832A3 Enzymatic ligation of nucleic acids |
| 01/10/2013 | WO2012092327A3 Methods to determine zygosity in a bulked sample |
| 01/10/2013 | WO2012083072A3 LIGATION METHOD EMPLOYING EUKARYOTIC tRNA LIGASE |
| 01/10/2013 | WO2012082753A3 Polymerization of nucleic acids using activation by polyphosphorolysis (app) reactions |
| 01/10/2013 | WO2012078374A3 Microorganism concentration process and device |
| 01/10/2013 | US20130013219 Determining Susceptibility To A Sudden Cardiac Event |
| 01/10/2013 | US20130012860 Methods and compositions to predict and detect acute rejection |
| 01/10/2013 | US20130012797 Method for managing treatment of a particular health condition via a mobile phone device |
| 01/10/2013 | US20130012604 Methods of using prdm1 genetic variants to prognose, diagnose and treat inflammatory bowel disease |
| 01/10/2013 | US20130012602 Methods of using znf365 genetic variants to diagnose crohn's disease |
| 01/10/2013 | US20130012559 Molecular genetic approach to treatment and diagnosis of alcohol and drug dependence |
| 01/10/2013 | US20130012550 Methods for prognosis and monitoring cancer therapy |
| 01/10/2013 | US20130012527 Preq1 riboswitches and methods and compositions for use of and with preq1 riboswitches |
| 01/10/2013 | US20130012497 Methods for detecting adhd susceptibility and predicting severity and long term outcome of adhd symptoms |
| 01/10/2013 | US20130012451 Compositions and methods for inhibiting mmp-9-mediated cell migration |
| 01/10/2013 | US20130012429 Anti-viral therapy |
| 01/10/2013 | US20130012411 Testing a patient population having a cardiovascular condition for drug efficacy |
| 01/10/2013 | US20130012410 Methods and materials for detecting colorectal cancer and adenoma |
| 01/10/2013 | US20130012409 Diagnostic and Prognostic Markers for Cancer |
| 01/10/2013 | US20130012408 Method for determination of onset risk of glaucoma |
| 01/10/2013 | US20130012404 Culture method, evaluation method and storage method for cancer-tissue-derived cell mass or aggregated cancer cell mass |
| 01/10/2013 | US20130012401 Single nucleotide polymorphisms associated with dietary weight loss |
| 01/10/2013 | US20130012399 Sequencing methods and compositions |
| 01/10/2013 | US20130012398 Methods for small RNA sequencing |
| 01/10/2013 | US20130011927 Detection of immobilized nucleic acid |
| 01/10/2013 | US20130011918 Methods for telomere length and genomic dna quality control and analysis in pluripotent stem cells |
| 01/10/2013 | US20130011902 Stimulation of the synthesis of the activity of an isoform of lysyl oxidase-like loxl for stimulating the formation of elastic fibers |
| 01/10/2013 | US20130011871 Sterilizable chemistry for test elements |
| 01/10/2013 | US20130011870 Method For Assaying Diseases Characterized By Dyslipidemia |
| 01/10/2013 | US20130011861 Modulators of p-selectin glycoprotein ligand 1 |
| 01/10/2013 | US20130011850 Steroidogenesis modified cells and methods for screening for endocrine disrupting chemicals |
| 01/10/2013 | US20130011849 Methods for Detection of Biological Substances |
| 01/10/2013 | US20130011847 Estrogen receptors and methods of use |
| 01/10/2013 | US20130011846 Delta 17 desaturase and its use in making polyunsaturated fatty acids |
| 01/10/2013 | US20130011845 Microrna regulating the insulin signaling pathway, and method for screening material for controlling the action of a target thereof |
| 01/10/2013 | US20130011844 Novel Biomarker Indicative of Ischemic Brain Injury and Its Use |
| 01/10/2013 | US20130011843 Tissue separation method |
| 01/10/2013 | US20130011841 Genetic Association of Polymorphisms in Perilipin (PLIN) Gene With Resistance to Weight Loss |
| 01/10/2013 | US20130011840 Methods, Compositions, and Kits Comprising Linker Probes for Quantifying Polynucleotides |
| 01/10/2013 | US20130011839 Methods for the Reduction of Stutter in Microsatellite Amplification |
| 01/10/2013 | US20130011838 Kits And Methods For Assessing Oxidative Stress |
| 01/10/2013 | US20130011837 Assays for Affinity Profiling of Nucleic Acid Binding Proteins |
| 01/10/2013 | US20130011835 Compositions and methods for treating inflammation |
| 01/10/2013 | US20130011834 Mean dna copy number of chromosomal regions is of prognostic significance in cancer |
| 01/10/2013 | US20130011833 Method for identifying nucleic acids bound to an analyte |
| 01/10/2013 | US20130011831 Compositions And Methods For The Rapid Detection Of Legionella pneumophila |
| 01/10/2013 | US20130011829 Device and methods for quantifying analytes |
| 01/10/2013 | US20130011828 Use |
| 01/10/2013 | US20130011826 Methods and kits for decreasing interferences from leukocytes in specific binding assays |
| 01/10/2013 | US20130011528 On-Line System, Method of its Calibration and Simultaneous Detection of Antibiotic Residues and Their Concentration in Milk |
| 01/10/2013 | US20130011496 Cancer testis antigens as biomarkers in non-small cell lung cancer |
| 01/10/2013 | US20130011428 Novel streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof |
| 01/10/2013 | US20130011425 Rapid, efficient purification of hsv-specific t-lymphocytes and hsv antigens identified via same |
| 01/10/2013 | US20130011423 Metalloproteinase oligopeptides and their therapeutic use |
| 01/10/2013 | US20130011409 Compositions, Kits, and Methods for the Diagnosis, Prognosis, Monitoring, Treatment and Modulation of Post-Transplant Lymphoproliferative Disorders and Hypoxia Associated Angiogenesis Disorders Using Galectin-1 |
| 01/10/2013 | US20130011404 Methods and Compositions for Regulating Musashi Function |
| 01/10/2013 | US20130011392 Method for assessing the ability of a patient to respond to or be safely treated by a nucleoside analog based-chemotherapy |
| 01/10/2013 | US20130011380 Use of Cytidine Deaminase-Related Agents to Promote Demethylation and Cell Reprogramming |
| 01/10/2013 | US20130011371 ESTABLISHMENT OF PATIENT- OR PERSON- SPECIFIC CARDIAC MYOCYTE CELL LINES FROM HUMAN INDUCED PLURIPOTENT STEM CELLS (iPSCs) |
| 01/10/2013 | US20130011338 Cupredoxin derived transport agents and methods of use thereof |
| 01/10/2013 | US20130011334 Modified ubiquitin proteins having a specific binding activity for the extradomain b of fibronectin |
| 01/10/2013 | US20130011333 Methods and Compositions for Nanoparticle-Mediated Cancer Cell-Targeted Delivery |
| 01/10/2013 | DE102011106547A1 Method and device useful e.g. for inactivating bacterial species comprising Escherichia coli in whole blood, where method comprises generating electromagnetic or electric field by applying low direct current and inactivating physiologically |
| 01/10/2013 | CA2840971A1 Assay |
| 01/10/2013 | CA2840964A1 Direct amplification and detection of viral and bacterial pathogens |
| 01/10/2013 | CA2840949A1 Reagent storage on a droplet actuator |
| 01/10/2013 | CA2840687A1 Discovery of a somatic mutation in myd88 gene in lymphoplasmacytic lymphoma |
| 01/10/2013 | CA2840558A1 Methods of detecting gene fusions |
| 01/10/2013 | CA2840526A1 Method to determine dna mismatch repair function |
| 01/10/2013 | CA2840492A1 Thermal convection polymerase chain reaction device |
| 01/10/2013 | CA2838091A1 Hiv-1 genotyping assay for global surveillance of hiv-1 drug resistance |
| 01/09/2013 | EP2544006A1 Biomarker combinations for colorectal cancer |
| 01/09/2013 | EP2544001A2 Measuring multiple analytes over a broad range of concentrations using optical diffraction |
| 01/09/2013 | EP2543742A1 Quantification of nucleic acid molecules using multiplex PCR |
| 01/09/2013 | EP2543741A1 Insect resistant plant |
| 01/09/2013 | EP2543740A2 Consensus coding sequences of human colorectal cancers |
| 01/09/2013 | EP2543739A1 Consensus coding sequences of human colorectal cancers |
| 01/09/2013 | EP2543738A2 Random RNAi libraries, methods of generating same, and screening methods utilizing same |
| 01/09/2013 | EP2543737A2 Method for detecting nucleic acids by promoting branched dna complex formation |
| 01/09/2013 | EP2543721A1 Fermentive production of isobutanol using highly active ketol-acid reductoisomerase enzymes |
| 01/09/2013 | EP2543706A2 Stabilizer of color former and use thereof |
| 01/09/2013 | EP2542892A2 Prognostic marker for cryoglobulinemic vasculitis and b cell malignancies in hcv infected patients |
| 01/09/2013 | EP2542888A2 Method and kit for isolating target cell |
| 01/09/2013 | EP2542702A1 A method to predict the pattern of locomotion in horses |
| 01/09/2013 | EP2542701A1 Biomarkers of osteoarthritis |
| 01/09/2013 | EP2542700A2 Integrated assay that combines flow-cytometry and multiplexed hpv genotype identification |
| 01/09/2013 | EP2542699A1 Methods for determining responsiveness to a drug based upon determination of ras mutation and/or ras amplification |
| 01/09/2013 | EP2542698A1 Detection of dna methylation |
| 01/09/2013 | EP2542697A1 Methods and compositions for diagnosis and prognosis of renal injury and renal failure in a non-surgical icu population |
| 01/09/2013 | EP2542696A1 Biomarkers for theranostics |
| 01/09/2013 | EP2542695A2 Method of diagnostic of obesity |
| 01/09/2013 | EP2542694A2 Method for evaluating the sensibilisation potential of a test compound |
| 01/09/2013 | EP2542693A1 Method for detecting the presence of specific micro-organisms and device for the same |
| 01/09/2013 | EP2542692A1 Method for selecting patients for treatment with an egfr inhibitor |
| 01/09/2013 | EP2542691A1 Gene sets for detection ultraviolet a exposure and methods of use thereof |
| 01/09/2013 | EP2542690A2 Method of diagnostic of inflammatory bowel diseases |